Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release

Cited by (723)

Items 101–200 of 723

1. High Mobility Group Box-1 (HMGB1) Participates in the Pathogenesis of Alcoholic Liver Disease (ALD)
   Xiaodong Ge, Daniel James Antoine, Yongke Lu, Elena Arriazu, Tung-Ming Leung, Arielle L. Klepper, Andrea D. Branch, Maria Isabel Fiel, Natalia Nieto · 2014 · Journal of Biological Chemistry
2. The alarmin IL-1α is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticles
   Rabolli, Virginie, Badissi, Anissa Alami, Devosse, Raynal, Uwambayinema, Francine, Yakoub, Yousof, Palmai-Pallag, Mihaly, Lebrun, Astrid, De Gussem, Valentin, Couillin, Isabelle, Ryffel, Bernard et al. · 2014 · Particle and Fibre Toxicology
3. Hepatocyte HSPA12A inhibits macrophage chemotaxis and activation to attenuate liver ischemia/reperfusion injury via suppressing glycolysis-mediated HMGB1 lactylation and secretion of hepatocytes
   Shuya Du, Xiaojin Zhang, Yunxiao Jia, Peipei Peng, Qiuyue Kong, Surong Jiang, Yuehua Li, Chuanfu Li, Zhengnian Ding, Li Liu · 2023 · Theranostics
4. Redox regulation of cardiovascular inflammation – Immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species
   Philip Wenzel, Sabine Kossmann, Thomas F. Münzel, Andreas Daiber · 2017 · Free Radical Biology and Medicine
5. Toll-like receptor signaling and stages of addiction
   Fulton T. Crews, T. Jordan Walter, Leon G. Coleman, Ryan P. Vetreno · 2017 · Psychopharmacology
6. Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation
   Meihong Deng, Melanie J. Scott, Jie Fan, Timothy R. Billiar · 2019 · Journal of Leukocyte Biology
7. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation
   Md Ashik Ullah, Zhixuan Loh, Wan Jun Gan, Vivian Zhang, Huan Yang, Jian Hua Li, Yasuhiko Yamamoto, Ann Marie Schmidt, Carol Lyn Armour, J. Margaret Hughes et al. · 2014 · Journal of Allergy and Clinical Immunology
8. Trauma-Induced Damage-Associated Molecular Patterns-Mediated Remote Organ Injury and Immunosuppression in the Acutely Ill Patient
   Mickaël Vourc’h, Antoine Roquilly, Karim Asehnoune · 2018 · Frontiers in Immunology
9. High mobility group box 1 orchestrates tissue regeneration via CXCR4
   Mario Tirone, Ngoc Lan Tran, Chiara Ceriotti, Andrea Gorzanelli, Monica Canepari, Roberto Bottinelli, Angela Raucci, Stefania Di Maggio, César A. Santiago, Mario Mellado et al. · 2017 · The Journal of Experimental Medicine
10. The Role of Metabolic Remodeling in Macrophage Polarization and Its Effect on Skeletal Muscle Regeneration
    F. De Santa, L. Vitiello, Alessio Torcinaro, E. Ferraro · 2019 · Antioxidants and Redox Signaling
11. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review
    Ben Lü, Ce Wang, Mao Wang, Wei Li, Fangping Chen, Kevin J. Tracey, Haichao Wang · 2014 · Expert Review of Clinical Immunology
12. Stress-induced neuroinflammatory priming: A liability factor in the etiology of psychiatric disorders
    Matthew G. Frank, Michael D. Weber, Linda R. Watkins, Steven F. Maier · 2015 · Neurobiology of Stress
13. Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications
    Ray Kiran Boyapati, Adriano Giorgio Rossi, Jack Satsangi, Gwo‐Tzer Ho · 2016 · Mucosal Immunology
14. High-mobility group box family of proteins: ligand and sensor for innate immunity
    Hideyuki Yanai, Tatsuma Ban, Tadatsugu Taniguchi · 2012 · Trends in Immunology
15. Targeting HMGB1 in the treatment of sepsis
    Haichao Wang, M.F. Ward, Andrew E. Sama · 2014 · Expert Opinion on Therapeutic Targets
16. The Janus face of HMGB1 in heart disease: a necessary update
    Angela Raucci, Stefania Di Maggio, Francesco Scavello, Alessandro D’Ambrosio, Marco Emilio Bianchi, Maurizio Colognesi Capogrossi · 2018 · Cellular and Molecular Life Sciences
17. Regulation of wound healing and organ fibrosis by toll-like receptors
    Peter Huebener, Robert F. Schwabe · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
18. Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
    Flavia Radogna, Marc F. Diederich · 2018 · Biochemical Pharmacology
19. TLR activation regulates damage‐associated molecular pattern isoforms released during pyroptosis
    Sanna Nyström, Daniel James Antoine, Peter Lundbäck, John George Lock, Andreia Florina Niță, Kari Högstrand, Alf Grandien, Helena Erlandsson-Harris, Ulf Andersson, Steven E. Applequist · 2012 · The EMBO Journal
20. Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury
    Clifford L. Eastman, Raimondo D’Ambrosio, Thota Ganesh · 2019 · Neuropharmacology
21. High-mobility group box 1 is a novel deacetylation target of Sirtuin1
    May M. Rabadi, Sandhya Xavier, Radovan Vasko, Kavneet Kaur, Michael S. Goligorksy, Brian B. Ratliff · 2014 · Kidney International
22. Cell Death-Associated Molecular-Pattern Molecules: Inflammatory Signaling and Control
    Beatriz A. Sangiuliano, Marcela Pérez-Sosa, Dayson Moreira, José Ernesto Belizário · 2014 · Mediators of Inflammation
23. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
    Jessica P Roelands, Peter J.K. Kuppen, Louis Vermeulen, Cristina Maccalli, Julie V. Decock, Ena Wang, Francesco Maria Marincola, Davide Bedognetti, Wouter Hendrickx · 2017 · International Journal of Molecular Sciences
24. The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome
    Frank, Matthew G., Weber, Michael D., Fonken, Laura K., Hershman, Sarah A., Watkins, Linda R., Maier, Steven F. · 2016 · Brain, Behavior, and Immunity
25. Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies
    Simon Gebremeskel, Brent Johnston · 2015 · Oncotarget
26. Regulation of Posttranslational Modifications of HMGB1 During Immune Responses
    Yiting Tang, Xin Sheng Zhao, Daniel James Antoine, Xianzhong Xiao, Haichao Wang, Ulf Andersson, Timothy R. Billiar, Kevin J. Tracey, Ben Lü · 2015 · Antioxidants and Redox Signaling
27. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury
    Chao Deng, Lin Zhao, Zhi Ping Yang, Jiajia Shang, Changyu Wang, Mingzhi Shen, Shuai Jiang, Li Tian, Wencheng Di, Ying Chen et al. · 2021 · Acta Pharmacologica Sinica
28. Neuroinflammation: The central enabler of postoperative cognitive dysfunction
    Yang Liu, Wei Yang, Jinqi Xue, Juntong Chen, Shiqing Liu, Shijie Zhang, Xiaohui Zhang, Xi Gu, Youjing Dong, Peng Qiu · 2023 · Biomedicine & Pharmacotherapy
29. Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
    Ruochan Chen, Wen Hou, Qiuhong Zhang, Rui Kang, Xuegong Fan, Daolin Tang · 2013 · Molecular Medicine
30. Emerging Roles for HMGB1 Protein in Immunity, Inflammation, and Cancer
    Ranzato, Elia, Martinotti, Simona, Patrone, Mauro · 2015 · ImmunoTargets and Therapy
31. Cysteines as Redox Molecular Switches and Targets of Disease
    Annamaria Fra, Edgar D. Yoboue, Roberto Sitia · 2017 · Frontiers in Molecular Neuroscience
32. The Role of High Mobility Group Box 1 in Innate Immunity
    Shin-Ae Lee, Man Sup Kwak, Sol Kim, Jeon‐Soo Shin · 2014 · Yonsei Medical Journal
33. Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes
    Huan Yang, Haichao Wang, Yaakov A. Levine, Manojkumar Gunasekaran, Yongjun Wang, Meghan E. Addorisio, Shu Zhu, Wei Li, Jianhua Li, Dominique P.V. de Kleijn et al. · 2016 · JCI Insight
34. Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses
    Pooja Mandke, Karen M. Vásquez · 2019 · DNA repair
35. Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent Secretion
    L. Mullen, Eva-Maria Hanschmann, Christopher Horst Lillig, Leonore A. Herzenberg, Pietro Ghezzi · 2015 · Molecular Medicine
36. Neutrophil myeloperoxidase diminishes the toxic effects and mortality induced by lipopolysaccharide
    Laurent Lionel Reber, Caitlin M. Gillis, Philipp M. Starkl, Friederike Jönsson, Riccardo Sibilano, Thomas Marichal, Nicolas Gaudenzio, Marion Berard, Stephan Rogalla, Christopher H. Contag et al. · 2017 · The Journal of Experimental Medicine
37. Neuroinflammation in Alzheimer’s disease: insights from peripheral immune cells
    Qiang Zhang, Guanhu Yang, Yuan Luo, Lai Jiang, Hao Chi, Gang Tian · 2024 · Immunity & Ageing
38. Aspirin’s Active Metabolite Salicylic Acid Targets High Mobility Group Box 1 to Modulate Inflammatory Responses
    Hyong Woo Choi, Miaoying Tian, Fei Song, Emilie Vénéreau, Alessandro Preti, Sang-Wook Park, Keith Hamilton, G.V.T. Swapna, Murli Manohar, Magali Moreau et al. · 2015 · Molecular Medicine
39. Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity
    Takahiro Horiuchi, Natsumi Sakata, Yoshihiro Narumi, Tomohiro Kimura, Takashi Hayashi, Keisuke Nagano, Keyue Liu, Masahiro Nishibori, Sohei Tsukita, Tetsuya Yamada et al. · 2017 · Journal of Biological Chemistry
40. DAMPs in the immunogenicity of cell death
    Ruochan Chen, Ju Zou, Jiao Liu, Rui Kang, Daolin Tang · 2025 · Molecular Cell
41. HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
    Hernandez, Celine, Huebener, Peter, Pradere, Jean-Philippe, Antoine, Daniel J., Friedman, Richard A., Schwabe, Robert F. · 2018 · Journal of Clinical Investigation
42. HMGB1 protein as a novel target for cancer
    Alok S. Tripathi, Kriti Shrinet, Arvind Kumar · 2019 · Toxicology Reports
43. HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities
    Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Iekhsan Othman, Mohd. Farooq Shaikh · 2020 · International Journal of Molecular Sciences
44. Role of HMGB1 in the Interplay between NETosis and Thrombosis in Ischemic Stroke: A Review
    Seung-Woo Kim, Ja-Kyeong Lee · 2020 · Cells
45. Mass Spectrometry-Based Methods for Identifying Oxidized Proteins in Disease: Advances and Challenges
    Verrastro, Ivan, Pasha, Sabah, Jensen, Karina, Pitt, Andrew, Spickett, Corinne · 2015 · Biomolecules
46. A Janus Tale of Two Active High Mobility Group Box 1 (HMGB1) Redox States
    Tang, Daolin, Billiar, Timothy R., Lotze, Michael T. · 2012 · Molecular Medicine
47. Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to G Alert
    Geoffrey Lee, Ana Isabel Espirito Santo, Stefan Zwingenberger, Lawrence X. Cai, Thomas Vogl, Marc Feldmann, Nicole J. Horwood, James K-K. Chan, Jagdeep Nanchahal · 2018 · Proceedings of the National Academy of Sciences
48. The Mechanisms and Physiological Relevance of Glycocalyx Degradation in Hepatic Ischemia/Reperfusion Injury
    Rowan F. van Golen, Megan J. Reiniers, Nienke Vrisekoop, Coert Jozef Zuurbier, Pim B. Olthof, Jacco van Rheenen, Thomas M. van Gulik, Barry J. Parsons, Michal Heger · 2013 · Antioxidants and Redox Signaling
49. A Systematic Nomenclature for the Redox States of High Mobility Group Box (HMGB) Proteins
    Daniel James Antoine, Helena Erlandsson Harris, Ulf Andersson, Kevin J. Tracey, Marco Emilio Bianchi · 2014 · Molecular Medicine
50. Autophagy deficiency in macrophages enhances NLRP3 inflammasome activity and chronic lung disease following silica exposure
    Jessop, Forrest, Hamilton, Raymond F., Rhoderick, Joseph F., Shaw, Pamela K., Holian, Andrij · 2016 · Toxicology and Applied Pharmacology
51. A novel high mobility group box 1 neutralizing chimeric antibody attenuates drug‐induced liver injury and postinjury inflammation in mice
    Peter Lundbäck, Jonathan D. Lea, Agnieszka Sowińska, Lars Ottosson, Camilla Melin Fürst, Johanna Stéen, Cecilia Aulin, Joanna I. Clarke, Anja Kipar, Lena Klevenvall et al. · 2016 · Hepatology
52. Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1
    Yong‐Jie Lian, Hong Gong, Tengyun Wu, Wenjun Su, Yi Zhang, Yuanyuan Yang, Peng Wei, Ting Zhang, Jiang‐Rui Zhou, Chun‐Lei Jiang et al. · 2016 · Brain Behavior and Immunity
53. HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway
    Bo Wang, Yong‐Jie Lian, Wenjun Su, Peng Wei, Xin Wen Dong, Lin-Lin Liu, Hong Gong, Ting Zhang, Chun‐Lei Jiang, Yunxia Wang · 2017 · Brain Behavior and Immunity
54. PKR-Dependent Inflammatory Signals
    Rui Kang, Daolin Tang · 2012 · Science Signaling
55. White matter damage after traumatic brain injury: A role for damage associated molecular patterns
    Molly Braun, Kumar Vaibhav, Nancy Saad, Sumbul Fatima, John R. Vender, Babak Baban, Md Nasrul Hoda, Krishnan M. Dhandapani · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
56. Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes
    Natalie E. Stevens, Marianne J. Chapman, Cara K. Fraser, Tim R. Kuchel, John D. Hayball, Kerrilyn R. Diener · 2017 · Scientific Reports
57. High-mobility group box-1 and its role in angiogenesis
    Shuai Yang, Linxinyu Xu, Tianshu Yang, Fang Wang · 2014 · Journal of Leukocyte Biology
58. Antitumor Immunity Induced after α Irradiation
    Jean‐Baptiste Gorin, Jérémie Ménager, Sébastien Gouard, Catherine Maurel, Yannick Guilloux, Alain Faivre-Chauvet, Alfred Morgenstern, Frank Bruchertseifer, Michel Chérel, François Davodeau et al. · 2014 · Neoplasia
59. Thiol–Disulfide Exchange Reactions in the Mammalian Extracellular Environment
    Michael C. Yi, Chaitan Khosla · 2016 · Annual Review of Chemical and Biomolecular Engineering
60. High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target
    Sonya VanPatten, Yousef Al‐Abed · 2017 · Journal of Medicinal Chemistry
61. Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies
    Jacob P. van Vloten, Samuel Tekeste Workenhe, Sarah K. Wootton, Karen Louise Mossman, Byram W. Bridle · 2018 · The Journal of Immunology
62. Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy
    Lauren Elizabeth Walker, Federica Frigerio, Teresa Ravizza, Emanuele Ricci, Karen Tse, Rosalind E. Jenkins, Graeme John Sills, Andrea Jorgensen, Luca Porcu, Thimmasettappa Thippeswamy et al. · 2017 · Journal of Clinical Investigation · Retracted
63. Red Blood Cells Induce Necroptosis of Lung Endothelial Cells and Increase Susceptibility to Lung Inflammation
    Danielle Qing, David Conegliano, Michael G. S. Shashaty, Jeongyun Seo, John P. Reilly, George Scott Worthen, Dongeun Huh, Nuala J. Meyer, Nilam S. Mangalmurti · 2014 · American Journal of Respiratory and Critical Care Medicine
64. Immunogenic Apoptotic Cell Death and Anticancer Immunity
    Peter Vandenabeele, Katrien Vandecasteele, Claus Bachert, Olga Krysko, Dmitri V. Krysko · 2016 · Advances in experimental medicine and biology
65. The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies
    Elke Kooijman, Cora H. A. Nijboer, Cindy T. J. van Velthoven, Annemieke Kavelaars, Jozef Kesecioğlu, Cobi J. Heijnen · 2014 · Journal of Neuroinflammation
66. Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy
    Teng Liu, Pei Pei, Wenhao Shen, Lin Tao Hu, Kai Yang · 2023 · Small Methods
67. Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance
    Mingzhu He, Marco Emilio Bianchi, Tom R. Coleman, Kevin J. Tracey, Yousef Al‐Abed · 2018 · Molecular Medicine
68. Oxidative Stress Elicits Platelet/Leukocyte Inflammatory Interactions via HMGB1: A Candidate for Microvessel Injury in Sytemic Sclerosis
    Norma Maugeri, Patrizia Querini Rovere, Mattia Baldini, Elena Marina Baldissera, Maria Grazia Sabbadini, Marco Emilio Bianchi, Angelo Andrea Manfredi · 2013 · Antioxidants and Redox Signaling
69. Lipopolysaccharide delivery systems in innate immunity
    Jiao Liu, Rui Kang, Daolin Tang · 2024 · Trends in Immunology
70. Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice
    Min Yang, Daniel James Antoine, James L. Weemhoff, Rosalind E. Jenkins, Anwar I. Farhood, Kevin B. Park, Hartmut Jaeschke · 2014 · Liver Transplantation
71. Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
    María Julia Lamberti, Annunziata Nigro, Fátima María Mentucci, Natalia Belén Rumie Vittar, Vincenzo Casolaro, Jessica Dal Col · 2020 · Pharmaceutics
72. Extracellular High-Mobility Group Box 1 Protein (HMGB1) as a Mediator of Persistent Pain
    Nilesh M. Agalave, Camilla I. Svensson · 2014 · Molecular Medicine
73. Emerging role of HMGB1 in lung diseases: friend or foe
    Junying Ding, Xuran Cui, Qingquan Liu · 2016 · Journal of Cellular and Molecular Medicine
74. The Role of High Mobility Group Box 1 in Ischemic Stroke
    Yingze Ye, Zhi Rong Zeng, Tong Jin, Hongfei Zhang, Xiaoxing Xiong, Lijuan Gu · 2019 · Frontiers in Cellular Neuroscience
75. The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases
    Mao Wang, Alex G. Gauthier, Lee-Anne Daley, Katelyn Dial, Jiaqi Wu, Joanna Woo, Mosi Lin, Charles R. Ashby, Lin L. Mantell · 2019 · Antioxidants and Redox Signaling
76. HMGB1 and repair: focus on the heart
    Laura Pellegrini, Eleonora Foglio, Elena Pontemezzo, Antonia Germani, Matteo Antonio Russo, Federica Limana · 2018 · Pharmacology & Therapeutics
77. Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure
    Katelyn Arnold, Yongmei Xu, Erica Sparkenbaugh, Miaomiao Li, Xiaorui Han, Xing Zhang, Ke Xia, Mark Piegore, Fuming Zhang, Xiaoxiao Zhang et al. · 2020 · Science Translational Medicine
78. Activation of Plant Innate Immunity by Extracellular High Mobility Group Box 3 and Its Inhibition by Salicylic Acid
    Hyong Woo Choi, Murli Manohar, Patricia M. Manosalva, Miaoying Tian, Magali Moreau, Daniel F. Klessig · 2016 · PLoS Pathogens
79. Real-time Kinetics of High-mobility Group Box 1 (HMGB1) Oxidation in Extracellular Fluids Studied by in Situ Protein NMR Spectroscopy
    Levani Zandarashvili, Debashish Sahu, Kwanbok Lee, Yong Sun Lee, Pomila Singh, Krishna Rajarathnam, Junji Iwahara · 2013 · Journal of Biological Chemistry
80. The Alarmin Properties of DNA and DNA-associated Nuclear Proteins
    Melinda Magna, David S. Pisetsky · 2016 · Clinical Therapeutics
81. HMGB1 redox during sepsis
    Wasan Abdulmahdi, Devika Patel, May M. Rabadi, Tala Azar, Edson Jules, Mark Lipphardt, Rameen Hashemiyoon, Brian B. Ratliff · 2017 · Redox Biology
82. HMGB1, an innate alarmin, plays a critical role in chronic inflammation of adipose tissue in obesity
    Jing Zhang, Lei Zhang, Shu Zhang, Qilin Yu, Fei Xiong, Kun Huang, Cong‐Yi Wang, Ping Chang Yang · 2017 · Molecular and Cellular Endocrinology
83. Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke
    Stefan Roth, Vikramjeet Singh, Steffen Tiedt, Lisa Schindler, G. Carl Huber, Arie Geerlof, Daniel James Antoine, Antoine Anfray, Cyrille Orset, Maxime Gauberti et al. · 2018 · Science Translational Medicine
84. Peroxiredoxin-mediated disulfide bond formation is required for nucleocytoplasmic translocation and secretion of HMGB1 in response to inflammatory stimuli
    Man Sup Kwak, Hee Sue Kim, Khulan Lkhamsuren, Young Hun Kim, Myeong Gil Han, Jae Min Shin, In Ho Park, Woo Joong Rhee, Se Kyoung Lee, Sue Goo Rhee et al. · 2019 · Redox Biology
85. The Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction
    Helena Block, Jan Rossaint, Alexander Zarbock · 2022 · Cells
86. A FRET biosensor for necroptosis uncovers two different modes of the release of DAMPs
    Shin Murai, Yoshifumi Yamaguchi, Yoshitaka Shirasaki, Mai Yamagishi, Ryodai Shindo, Joanne M. Hildebrand, R. Miura, Osamu Nakabayashi, Mamoru Totsuka, Taichiro Tomida et al. · 2018 · Nature Communications
87. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis
    Mei Zong, Joseph D. Bruton, Cecilia Grundtman, Huan Yang, Jian Hua Li, Helene Alexanderson, Karin Palmblad, Ulf Andersson, Helena Erlandsson Harris, Ingrid E. Lundberg et al. · 2012 · Annals of the Rheumatic Diseases
88. The Multitasking Potential of Alarmins and Atypical Chemokines
    Aphrodite Kapurniotu, Özgün Gökçe, Jürgen Bernhagen · 2019 · Frontiers in Medicine
89. Celastrol exerts a neuroprotective effect by directly binding to HMGB1 protein in cerebral ischemia–reperfusion
    Dandan Liu, Piao Luo, Liwei Gu, Qian Zhang, Peng Gao, Yongping Zhu, Xiao Chen, Qiuyan Guo, Junzhe Zhang, Nan Ma et al. · 2021 · Journal of Neuroinflammation
90. Immunogenicity of ferroptosis in cancer: a matter of context?
    Elena Catanzaro, Robin Demuynck, Faye Naessens, Lorenzo Galluzzi, Dmitri V. Krysko · 2024 · Trends in cancer
91. The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer
    Kerrilyn R. Diener, Noor Al‐Dasooqi, Erin L. Lousberg, John D. Hayball · 2013 · Immunology and Cell Biology
92. Role of Extracellular Damage-Associated Molecular Pattern Molecules (DAMPs) as Mediators of Persistent Pain
    Jungo Kato, Camilla I. Svensson · 2015 · Progress in molecular biology and translational science
93. Disulfide High‐Mobility Group Box 1 Drives Ischemia‐Reperfusion Injury in Human Liver Transplantation
    Rebecca A. Sosa, Allyson Q. Terry, Fady M. Kaldas et al. · 2020 · Hepatology
94. NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
    Claudia Cantoni, Leticía Huergo-Zapico, Monica Parodi, Marco Pedrazzi, Maria Cristina Mingari, Alessandro Moretta, Bianca Sparatore, Segundo R. Gonzalez, Daniel Olive, Cristina Bottino et al. · 2016 · Journal of Immunology Research
95. Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
    Lalitha Palanivelu, Ching‐Hsuan Liu, Liang Lin · 2023 · Frontiers in Immunology
96. Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression
    Haining Yang, Laura Pellegrini, Andrea Napolitano, Carlotta Giorgi, Sandro Jube, Alessandro Preti, Cormac J. Jennings, Francesco De Marchis, Erin G. Flores, DAVID L. LARSON et al. · 2015 · Cell Death and Disease
97. Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing
    Gwo‐Tzer Ho, Jennifer Ann Cartwright, Emily J Thompson, Calum C. Bain, Adriano Giorgio Rossi · 2020 · Inflammatory Bowel Diseases
98. The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases
    Yun Ge, Man Huang, Yong-ming Yao · 2021 · Cells
99. Toll-like Receptor 4 (TLR4) Antagonist Eritoran Tetrasodium Attenuates Liver Ischemia and Reperfusion Injury through Inhibition of High-Mobility Group Box Protein B1 (HMGB1) Signaling
    Kerry-Ann McDonald, Hai Huang, Samer T. Tohme, Patricia Loughran, Kimberly M. Ferrero, Timothy R. Billiar, Allan Tsung · 2014 · Molecular Medicine
100. Photodynamic Modulation of Endoplasmic Reticulum and Mitochondria Network Boosted Cancer Immunotherapy
     Xiaoli Wang, Jieying Qian, Zhenyu Yang, Yang Song, Wenping Pan, Yayi Ye, Xiaohua Qin, Xianwu Yan, Xiaowan Huang, Xingwu Wang et al. · 2023 · Advanced Materials